Abstract:To give full prominence to the superiority of phenolic acid nutraceuticals syringic acid (SYRA) and gallic acid (GALA) in perfection of in vitro and in vivo performances for cardiotonic drug milrinone (MLN), and ulteriorly attain novice insights in the development of cardiotonic drug-nutraceutical cocrystals, two new solid forms of MLN including one cocrystal with SYRA, and one cocrystal hydrate with GALA─namely, MLN-SYRA (1) and MLN-GALA- H2O (2)─are first assembled and thoroughly characterized. The single-crystal X-ray diffraction showcases that both cocrystal 1 and cocrystal hydrate 2 have three-dimensional supramolecular structures controlled by hydrogen-bonding and aromatic packing interactions, where the hydrogen-bonding dimers of MLN itself still remain in 1 but are broken in 2, forming hydrophobic cavities in the former and hydrophilic ones in the latter. Such structural characteristics and aggregation motifs, because of the introduction of different phenolic acids in the crystalline lattices, have important influence on the improvements of dissolvability and permeability for the two crystalline forms, and in accordance with the theoretical studies. Intriguingly, the optimized in vitro biopharmaceutical properties can be effectually transformed to satisfactory in vivo pharmacokinetic peculiarity, performing the increased bioavailability and extended half-life. Thus, the current research not only offers promising solid-state forms for MLN with development foregrounds, but opens up new applications for nutraceutical phenolic acids in cardiotonic pharmaceutical cocrystals.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.cgd.1c01143.Screenings for the cocrystal of MLN with phenolic acids; screenings for the MLN-SYRA cocrystal with different methods; screenings for the MLN-GALA-H2O cocrystal hydrate with different experimental parameters; some parameters related to molecular electrostatic potentials, DSC and TG profiles of starting materials, powder XRD comparison of simulated pattern for the cocrystals and the residual solids after the solubility tests, IDR profiles of MLN, cocrystal 1 and cocrystal hydrate 2 at pH 1.2, 4.0, and 6.8 buffers (PDF)This article has not yet been cited by other publications.

An Integrated Experimental and Theoretical Research on Ternary Salt-Cocrystal of Anti-Heart Failure Medicine Milrinone with Different Substituted Benzoic Acids

Cocrystallization-Driven Double-Optimized Stratagem toward Directional Self-Assembly for the First Ternary Salt Cocrystal of Cardiotonic Drug Milrinone with Different Phenolic Acids Exhibits Optimal <i>In Vitro</i>/<i>Vivo</i> Biopharmaceutical Peculiarities

Cocrystals and Salts of Milrinone with Fluoro Coformers: Improving Drug Dissolution and Diffusion and Calculating Normalized Diffusion for Pharmaceutical Cocrystals

A New Strategy to Design Isostructural Salts: the Case of the Antitumor Drug Dimethylaminomicheliolide

Drug-nutrient cocrystallization-driven strategy towards self-assembly of milrinone and ferulic acid provides an exemplification in perfecting in vitro/vivo characteristics of anti-heart failure drugs

The First Cocrystallization of Milrinone with Nutraceuticals: The Adjusting Effects of Hydrophilicity/Hydrophobicity in Cavities on the In Vitro/In Vivo Properties of the Cocrystals

The Comparative Study of Cocrystal/salt in Simultaneously Improving Solubility and Permeability of Acetazolamide

Salt Cocrystal of Diclofenac Sodium-L-Proline: Structural, Pseudopolymorphism, and Pharmaceutics Performance Study

Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance

Improvement of the Thermal Stability and Aqueous Solubility of Three Matrine Salts Assembled by the Similar Structure Salt Formers

A Novel Cocrystal of Metformin Hydrochloride with Citric Acid: Systematic Synthesis and Computational Simulation

Multi-component Crystal Strategy for Improving Water Solubility and Antifungal Activity of Climbazole

Beating Brine. Supramolecular Crosslinker gives Salt Resistant PIC Micelles and Improved MRI Contrast Agents.

Simultaneous Improvement of Dissolution Behavior and Oral Bioavailability of Antifungal Miconazole via Cocrystal and Salt Formation

Novel Co-Crystal of 3-Methylcinnamic Acid with Berberine(1:1): Synthesis, Characterization, and Intestinal Absorption Property

Tetramethylpyrazine Cocrystals with Cinnamic Acid and Its Derivatives: Crystal Structures, Theoretical Computations, and Sublimation Behavior Studies

New Lidocaine-Based Pharmaceutical Cocrystals: Preparation, Characterization, and Influence of the Racemic vs. Enantiopure Coformer on the Physico-Chemical Properties

Synthesis, Structural Characterization and Hirshfeld Analysis Studies of Three Novel Co-Crystals of Trans-4-[(2-amino-3,5-dibrobenzyl) Amino] Cyclohexanol with Hydroxyl Benzoic Acids

Structural landscape on a series of rhein: Berberine cocrystal salt solvates: The formation, dissolution elucidation from experimental and theoretical investigations

Improving Solubility and Avoiding Hygroscopicity of Tetrahydropalmatine by Forming a Pharmaceutical Salt Cocrystal via CAHBs

Study on co-amorphous emerging solubilization behavior after gelation during dissolution: The importance of complexation and anti-crystallization